Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Baxter International (NY:BAX)

17.70 -0.30 (-1.64%)
Streaming Delayed Price Updated: 12:24 PM EST, Nov 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Baxter International

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Medical Devices Giant Baxter Secures FDA Approval For New Infusion Pump System
FDA clears Baxter's Novum IQ LVP & SYR infusion pumps with Dose IQ Safety Software, streamlining training & reducing cognitive burden. Explore enhanced safety features & EMR interoperability. 
Via Benzinga
Becton, Dickinson And Co. Dividend Stock Analysis
Becton, Dickinson, and Co. provides a wide range of medical devices and diagnostic products used in hospitals, doctors' offices, research labs, and other settings. 
Via Talk Markets
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Why Are Dialysis Provider Stocks Trading Higher On Tuesday?
Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks 
Via Benzinga
Stock Market Commentary: “Volumes Are The Name Of The Game…”
Short, intermediate, and long term outlook on the market. Plus, a deep dive into our thesis on Cooper Standard 
Via Talk Markets
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
Earnings Outlook For Baxter Intl
 
Via Benzinga
7 Analysts Have This to Say About Baxter Intl
 
Via Benzinga
What 4 Analyst Ratings Have To Say About Baxter Intl
 
Via Benzinga
Barclays Maintains Overweight Rating for Baxter Intl: Here's What You Need To Know
 
Via Benzinga
Baxter Says 2023 Performance Reflects Strategic Initiatives With New Operating Model Without BioPharma Solutions Unit
Baxter's Q4 2023 results: $3.89 billion revenue, surpassing consensus, 4% Y/Y growth. Strong sales in Medical Products, Therapies, Kidney Care, and Pharmaceuticals segments. 
Via Benzinga
Top Picks 2024: Baxter International
Baxter International (BAX) has four divisions: Medical Products & Therapies, Healthcare Systems & Technologies, Pharmaceuticals, and Kidney Care. The stock aggressively sold off ~65% 
Via Talk Markets
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records. 
Via Talk Markets
3 Of Our Favorite Dividend Stocks For The New Year
The S&P 500 Index appears to be wrapping up a strong year, registering a year-to-date total return of 22.2%. The good news is that there are still undervalued stocks with strong dividends to choose... 
Via Talk Markets
Topics Stocks
Don't Miss These 3 High-Yielding Dividend Stocks In Health Care Sector From Wall Street's Most Accurate Analysts
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high... 
Via Benzinga
Morgan Stanley Maintains Equal-Weight Rating for Baxter Intl: Here's What You Need To Know
 
Via Benzinga
Most Active Equity Options For Midday - Monday, Nov. 13
Here are the most active equity options for midday. 
Via Talk Markets
Why Is Dialysis Device And Kidney Care Provider Baxter Stock Trading Higher Today?
Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.71 billion, which beat the consensus of $3.69 billion, up 3% Y/Y on a reported basis and  
Via Benzinga
Most Active Equity Options For Midday - Wednesday, Oct. 12
Here are the most active equity options for midday. 
Via Talk Markets
Why Investors Punished Baxter International Stock Today
The latest data from the lab could spell trouble for the company. 
Via The Motley Fool
Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Tempest Therapeutics, Inc. (NASDAQ: TPST) shares jumped 1067% to $2.80 after the company released new data demonstrating superiority of TPST-1120 arm across multiple study endpoints in... 
Via Benzinga
What's Going On With Kidney Dialysis Provider Stocks Today?
DaVita Inc (NYSE: DVA), Fresenius Medical Care AG (NYSE: FMS), and Baxter International Inc (NYSE: BAX) shares fel 
Via Benzinga
Silk Road Medical, E2open And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
U.S. stock futures traded higher this morning on Wednesday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
“At The Starting Gate” Stock Market (And Sentiment Results)
The NAAIM (National Association of Active Investment Managers Index) (Video Explanation) dropped to 59.87% this week from 65.49% equity exposure last week. 
Via Talk Markets
S&P 500: Entertainment Giants, AI Play Lead Monday's 5 Best; Medtech Firms Sicken
DexCom and several medical products firms struggled. 
Via Investor's Business Daily
Software Update Leads To False Alarms In Baxter's Spectrum Infusion Pumps, Urgent Correction Underway
Baxter International Inc (NYSE: BAX) has  
Via Benzinga
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
Keybanc cut the price target for Baxter International Inc. (NYSE: BAX) from $53 to $51. Keybanc analyst Matthew Mishan maintained an Overweight rating. Baxter International shares rose 1.2% to $47.58... 
Via Benzinga
Baxter Posts Mixed Q2 Earnings, Stock Falls On Lagging FY23 Outlook
Baxter International Inc (NYSE: BAX) posted Q2 revenue of $3.71 billion, which missed the consensus of $3.79 billion, up 3% Y/Y on a reported basis and up  
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.